June 10, 2021

Transcarent Raises $58 Million in Series B Funding to Accelerate Consumer-Directed Health and Care Experience for Self-Insured Employers

SAN FRANCISCO–(BUSINESS WIRE)–Transcarent, a new and different consumer-directed health and care experience for employees of self-insured employers and their families, today announced a $58 million Series B investment led by General Catalyst and 7wireVentures, with participation from Merck Global Health Innovation Fund, Kleiner Perkins, Leaps by Bayer, GreatPoint Ventures, and Threshold Ventures along with existing investors Alta Partners and Jove Equity Partners. This round brings Transcaren


Leave Comment


Your Name *
Your Email *
Your Website
Comment *